Benzinga

Benzinga Japan

Benzinga

Benzinga Japan

Benzinga

Benzinga Japan
木曜日, 9 10

West Pharmaceutical Services Inc

WSTNYSE
Trade with Public
Trade with Public
$332.52
-4.42-1.31%
最終更新: Sep 10, 11:09 AM
概要ニュース業績予想イベント目標株価財務センチメント株主構成配当比較オプション株式レポート

West Pharmaceutical Servs Analyst Price Targets

Wall Street analyst price targets and consensus rating for West Pharmaceutical Servs (WST).

Price Target Range — 10 Quarters

Analyst Consensus — 12 Analysts

12Buy
Consensus RatingBuy# Analysts12Avg. Consensus PT$394Upside to Avg. PT+18.5%

Rating Trend — Last 9 Months

Recent Analyst Actions

View all ratings →
DateFirmAnalystActionRating ChangePrice Target
Sep 9, 2026UBSDoug SchenkelPT RaiseBuy$340→$415
Aug 3, 2026CitigroupJoanne WuenschPT RaiseBuy$400→$412
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
UBS Maintains Buy on West Pharmaceutical Servs, Raises Price Target to $415

UBS analyst Doug Schenkel maintains West Pharmaceutical Servs (NYSE:WST) with a Buy and raises the price target from $340 to $415.
Benzinga Newsdesk

PRO
Citigroup Maintains Buy on West Pharmaceutical Servs, Raises Price Target to $412

Citigroup analyst Joanne Wuensch maintains West Pharmaceutical Servs (NYSE:WST) with a Buy and raises the price target from $400 to $412.
Benzinga Newsdesk

PRO
Evercore ISI Group Maintains Outperform on West Pharmaceutical Servs, Raises Price Target to $425

Evercore ISI Group analyst Daniel Markowitz maintains West Pharmaceutical Servs (NYSE:WST) with a Outperform and raises the price target from $410 to $425.
Benzinga Newsdesk

PRO
BNP Paribas Initiates Coverage On West Pharmaceutical Servs with Outperform Rating, Announces Price Target of $447

BNP Paribas analyst Curtis Moiles initiates coverage on West Pharmaceutical Servs (NYSE:WST) with a Outperform rating and announces Price Target of $447.
Benzinga Newsdesk

PRO
Morgan Stanley Maintains Equal-Weight on West Pharmaceutical Servs, Raises Price Target to $365

Morgan Stanley analyst Kallum Titchmarsh maintains West Pharmaceutical Servs (NYSE:WST) with a Equal-Weight and raises the price target from $325 to $365.
Benzinga Newsdesk

PRO
Evercore ISI Group Maintains Outperform on West Pharmaceutical Servs, Raises Price Target to $410

Evercore ISI Group analyst Daniel Markowitz maintains West Pharmaceutical Servs (NYSE:WST) with a Outperform and raises the price target from $390 to $410.
Benzinga Newsdesk

データとAPI: Benzinga API · 株式ニュースAPI · アナリスト評価API · 企業ロゴAPI

市場データ提供元 Benzinga API

Benzinga

Benzinga Japan

ニュース

パートナーシップ

ベンジンガ・グローバル

© 2026 Benzinga | All Rights Reserved